BMRN BioMarin Pharmaceutical Inc

For the quarter ended 31/12/2022, BioMarin Pharmaceutical Inc's revenues increased by 6.37% and amounted to 537.54M. Net income increased by 96.26% to -249.00K. Net assets increased by 0.76% to 4.60B and EPS increased from -0.04 to 0.00.